CYP2B6 and tuberculosis: Both alleles are associated with lower CYP2B6 activity leading to pharmacogenetic implications with many drugs including the antidepressant bupropion29, antiretroviral efavirenz30, anti-tuberculosis rifamycins and ethionamide31, among others.